Patient Name : Mrs.

SAYALI KHARDE Collected : 22/Sep/2022 03:37PM

Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:17PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 05:22PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF HAEMATOLOGY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD-EDTA

HAEMOGLOBIN 12.8 g/dL 12-15 Spectrophotometer
PCV 38.00 % 36-46 Electronic pulse &
Calculation
RBC COUNT 4.28 Million/cu.mm 3.8-4.8 Electrical Impedence
MCV 88.9 fL 83-101 Calculated
MCH 30 pg 27-32 Calculated
MCHC 33.8 g/dL 31.5-34.5 Calculated
R.D.W 13.7 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 9,610 cells/cu.mm 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 63.8 % 40-80 Electrical Impedance
LYMPHOCYTES 24.9 % 20-40 Electrical Impedance
EOSINOPHILS 3.8 % 1-6 Electrical Impedance
MONOCYTES 7.2 % 2-10 Electrical Impedance
BASOPHILS 0.3 % <1-2 Electrical Impedance
CORRECTED TLC 9,610 Cells/cu.mm Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 6131.18 Cells/cu.mm 2000-7000 Electrical Impedance
LYMPHOCYTES 2392.89 Cells/cu.mm 1000-3000 Electrical Impedance
EOSINOPHILS 365.18 Cells/cu.mm 20-500 Electrical Impedance
MONOCYTES 691.92 Cells/cu.mm 200-1000 Electrical Impedance
BASOPHILS 28.83 Cells/cu.mm 0-100 Electrical Impedance
PLATELET COUNT 400000 cells/cu.mm 150000-410000 Electrical impedence

Page 1 of 8

SIN No:HA04005543
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:17PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 05:22PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF HAEMATOLOGY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

BLOOD GROUP ABO AND RH FACTOR , WHOLE BLOOD-EDTA

BLOOD GROUP TYPE O Microplate
Hemagglutination
Rh TYPE Positive Microplate
Hemagglutination

Page 2 of 8

SIN No:HA04005543
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 03:55PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 04:57PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF BIOCHEMISTRY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

GLUCOSE, RANDOM , SODIUM FLUORIDE 133 mg/dL 70-140 HEXOKINASE

PLASMA

Page 3 of 8

SIN No:BI11115152
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 05:18PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 07:06PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

HBA1C, GLYCATED HEMOGLOBIN , 5.1 % HPLC

WHOLE BLOOD-EDTA
ESTIMATED AVERAGE GLUCOSE (eAG) , 100 mg/dL Calculated
WHOLE BLOOD-EDTA

Comment:
Reference Range as per American Diabetes Association (ADA):
REFERENCE GROUP HBA1C IN %
NON DIABETIC ADULTS >18 YEARS <5.7
AT RISK (PREDIABETES) 5.7 – 6.4
DIAGNOSING DIABETES ≥ 6.5
DIABETICS
· EXCELLENT CONTROL 6–7
· FAIR TO GOOD CONTROL 7–8
· UNSATISFACTORY CONTROL 8 – 10
· POOR CONTROL >10
Note: Dietary preparation or fasting is not required.

1. A1C test should be performed at least two times a year in patients who are meeting treatment goals (and who have stable
glycemic control).
2. Lowering A1C to below or around 7% has been shown to reduce microvascular and neuropathic complications of type 1
and type 2 diabetes. When mean annual HbA1c is <1.1 times ULN (upper limit of normal), renal and retinal complications
are rare, but complications occur in >70% of cases when HbA1c is >1.7 times ULN.
3. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or
decrease mean erythrocyte age. HbA1c may not accurately reflect glycemic control when clinical conditions that affect
erythrocyte survival are present. Fructosamine may be used as an alternate measurement of glycemic control

Page 4 of 8

SIN No:BI11115153
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:22PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 05:26PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF IMMUNOLOGY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

THYROID STIMULATING HORMONE 6.770 µIU/mL 0.35-4.94 CMIA

(TSH) , SERUM

Comment:
TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH is a labile hormone & is secreted in a pulsatile manner
throughout the day and is subject to several non-thyroidal pituitary influences.Significant variations in TSH can occur with
circadian rhythm, hormonal status, stress, sleep deprivation, caloric intake, medication & circulating antibodies.
It is important to confirm any TSH abnormality in a fresh specimen drawn after ~ 3 weeks before assigning a diagnosis, as
the cause of an isolated TSH abnormality.
Bio Ref Range for TSH in uIU/ml (As per
For pregnant females
American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0

Page 5 of 8

SIN No:IM04361560
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:20PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 05:23PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF CLINICAL PATHOLOGY

ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

COMPLETE URINE EXAMINATION , URINE

PHYSICAL EXAMINATION
COLOUR PALE YELLOW PALE YELLOW Visual
TRANSPARENCY CLEAR CLEAR Visual
pH 7.5 5-7.5 DOUBLE INDICATOR
SP. GRAVITY 1.005 1.002-1.030 Bromothymol Blue
BIOCHEMICAL EXAMINATION
URINE PROTEIN NEGATIVE NEGATIVE PROTEIN ERROR OF
INDICATOR
GLUCOSE NEGATIVE NEGATIVE GLUCOSE OXIDASE
URINE BILIRUBIN NEGATIVE NEGATIVE AZO COUPLING
REACTION
URINE KETONES (RANDOM) NEGATIVE NEGATIVE SODIUM NITRO
PRUSSIDE
UROBILINOGEN NORMAL NORMAL MODIFED EHRLICH
REACTION
BLOOD NEGATIVE NEGATIVE Peroxidase
NITRITE NEGATIVE NEGATIVE Diazotization
LEUCOCYTE ESTERASE NEGATIVE NEGATIVE LEUCOCYTE
ESTERASE
CENTRIFUGED SEDIMENT WET MOUNT AND MICROSCOPY
PUS CELLS 2-3 /hpf 0-5
EPITHELIAL CELLS 1-2 /hpf <10
RBC NIL /hpf ≤2
CASTS NIL ≤2 Hyaline Cast
CRYSTALS ABSENT ABSENT

Page 6 of 8

SIN No:C01542049
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:22PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 06:03PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF SEROLOGY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

(VDRL) RPR QUALITATIVE , SERUM NON REACTIVE NON-REACTIVE IMMUNOCHROMATOGRAPHY

Comment:
This is a screening test and reactive results must be correlated with supportive clinical, historical and epidemiological evidence to
arrive at a final diagnosis. False positives may be seen in a variety of acute and chronic conditions. It is advisable to confirm
diagnosis by TPHA / FTA-Abs test.

HBS AG SCREENING(RAPID) , SERUM NON REACTIVE NON REACTIVE ICT

Comment:
HBsAg is the initial serological marker of acute infection with Hepatitis B which typically appears 2-3 months after infection and
disappears 12-20 weeks after onset of symptoms. Persistence of HBsAg for more than six months indicates development of
carrier state or chronic liver disease.

Note: This is only a Screening test. All reactive samples should be confirmed by confirmatory test.

Page 7 of 8
Patient Name : Mrs.SAYALI KHARDE Collected : 22/Sep/2022 03:37PM
Age/Gender : 29 Y 0 M 0 D /F Received : 22/Sep/2022 04:22PM
UHID/MR No : DPNE.0000238748 Reported : 22/Sep/2022 06:03PM
Visit ID : DPNEOPV239981 Status : Final Report
Ref Doctor : DR ASHA GAVADE Client Name : PUP UMANG HOSPITAL
IP/OP NO : Patient location : ,Pune

DEPARTMENT OF SEROLOGY
ANTE NATAL PACK
Test Name Result Unit Bio. Ref. Range Method

HIV RAPID , SERUM NON REACTIVE NON REACTIVE ICT

Comment:
This test is used for screening for HIV-1 and/or HIV-2 infection in asymptomatic patients. Negative HIV-1/-2 antigen and
antibody screening test results usually indicate absence of HIV-1 and HIV-2 infection. Reactive HIV-1/-2 antibody screening test
results suggest the presence of HIV-1 and/or HIV-2 infection, but it is not diagnostic for HIV infection. All samples detected
reactive must be confirmed by using HIV Western Blot.
Some samples show cross reactivity for HIV antibodies. Following factors are found to cause false positive HIV antibody test
results: Naturally occurring antibodies, Passive immunization, Leprosy, Renal Disorders, Tuberculosis, Myco-bacterium avium,
Herpes simplex, Hypergammaglobulinemia, Malignant neoplasms, Rheumatoid arthritis, Tetanus vaccination, Autoimmune
diseases, Blood Transfusion, Multiple myeloma, Haemophelia, Heat treated specimens, Lipemic serum, Anti-nuclear antibodies, T-
cell leukocyte antigen antibodies, Epstein Barr virus, HLA antibodies and other retroviruses

*** End Of Report ***

Page 8 of 8

SIN No:SE01344917
This test has been performed at Apollo Health and Lifestyle ltd- Sadashiv Peth Pune, Diagnostics Lab